In follow-up to a meeting with regulators from the Centers for Medicare & Medicaid, 19 leading cancer organizations submitted comments addressing inquiries regarding implementation of the Affordable Care Act requirement that mandates private insurers to provide coverage for routine patient costs associated with participation in approved clinical trials, effective in January 2014.

[Read the rest of this article...]